DePuy Synthes, Johnson & Johnson Company, Raynham, MA 02767, USA.
Johnson & Johnson, Real World Data Sciences, New Brunswick, NJ 08901, USA.
J Comp Eff Res. 2020 Aug;9(11):795-805. doi: 10.2217/cer-2019-0128. Epub 2020 Jul 9.
To examine the time-to-total knee replacement (TKR) surgery among patients with high-concentration nonavian high-molecular-weight hyaluronan injection (HMW-HA) compared with those without HA injections. Using MarketScan Commercial claims all patients aged 18-64 who underwent TKR surgery between 2008 and 2017 were identified. Time-to-TKR surgery was compared between patients receiving Orthovisc (Anika Therapeutics Inc. Bedford MA, USA, referred to as nonavian HMW-HA) injections and patients who did not receive an HA injection. The median time-to-TKR surgery was 893 days in the nonavian HMW-HA cohort and 399 days in the non-HA cohort (p < 0.001), a difference of 494 days (16.2 months). This study demonstrates that the time-to-TKR surgery is 16.2 months longer in patients who received treatment with nonavian HMW-HA injections.
为了考察高浓度非禽类高分子量透明质酸钠(HMW-HA)注射与未注射 HA 患者之间接受全膝关节置换术(TKR)的时间差异。本研究使用 MarketScan 商业索赔数据,确定了 2008 年至 2017 年间接受 TKR 手术的所有 18-64 岁患者。比较了接受 Orthovisc(Anika Therapeutics Inc.,马萨诸塞州贝德福德,美国,称为非禽类 HMW-HA)注射的患者与未接受 HA 注射的患者之间的 TKR 手术时间。非禽类 HMW-HA 组的 TKR 手术中位时间为 893 天,而非 HA 组为 399 天(p < 0.001),差异为 494 天(16.2 个月)。本研究表明,接受非禽类 HMW-HA 注射治疗的患者的 TKR 手术时间延长了 16.2 个月。